STRO vs. OSCR
STRO (Sutro Biopharma, Inc.) and OSCR (Oscar Health, Inc.) are both stocks. Both are in the Healthcare sector — STRO in Biotechnology, OSCR in Healthcare Plans. Over the past 5 years, STRO returned -32.33%/yr vs 13.02%/yr for OSCR. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
STRO vs. OSCR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, STRO achieves a 108.90% return, which is significantly lower than OSCR's 117.26% return.
STRO
- 1D
- -2.62%
- 1M
- -20.57%
- 6M
- 61.67%
- YTD
- 108.90%
- 1Y
- 198.40%
- 3Y*
- -18.41%
- 5Y*
- -32.33%
- 10Y*
- —
- ALL TIME*
- -20.85%
OSCR
- 1D
- -0.03%
- 1M
- -2.98%
- 6M
- 117.56%
- YTD
- 117.26%
- 1Y
- 129.90%
- 3Y*
- 60.93%
- 5Y*
- 13.02%
- 10Y*
- —
- ALL TIME*
- -2.60%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $128.55M | $136.76M | $181.50M | |
| $6.33M | $8.37M | $10.40M |
STRO vs. OSCR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
STRO Sutro Biopharma, Inc. | 108.90% | -37.12% | -57.11% | -46.91% | -45.70% | -33.51% |
OSCR Oscar Health, Inc. | 117.26% | 6.92% | 46.89% | 271.95% | -68.66% | -78.19% |
Correlation
The correlation between STRO and OSCR is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.15 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.22 |
Correlation (All Time) Calculated using the full available price history since Mar 3, 2021 | 0.23 |
The correlation between STRO and OSCR shifts across timeframes, from 0.12 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.
Fundamentals
STRO:
$233.90M
OSCR:
$8.09B
STRO:
-$15.28
OSCR:
-$0.14
STRO:
2.44
OSCR:
0.68
STRO:
$99.61M
OSCR:
$13.30B
STRO:
$83.46M
OSCR:
$895.79M
STRO:
-$105.17M
OSCR:
$19.23M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
STRO vs. OSCR — Risk / Return Rank
STRO
OSCR
STRO vs. OSCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sutro Biopharma, Inc. (STRO) and Oscar Health, Inc. (OSCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| STRO | OSCR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.51 | ||
| Sortino ratioReturn per unit of downside risk | +0.20 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.30 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 4.50 | 2.38 | +2.12 |
| Martin ratioReturn relative to average drawdown | 10.46 | 4.92 | +5.54 |
Loading charts...
Drawdowns
STRO vs. OSCR - Drawdown Comparison
The maximum STRO drawdown since its inception was -98.10%, roughly equal to the maximum OSCR drawdown of -94.15%. Use the drawdown chart below to compare losses from any high point for STRO and OSCR.
Loading charts...
Drawdown Indicators
| STRO | OSCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.10% | -94.15% | -3.95% |
Max Drawdown (1Y)Largest decline over 1 year | -44.78% | -51.71% | +6.93% |
Max Drawdown (3Y)Largest decline over 3 years | -90.72% | -53.39% | -37.33% |
Max Drawdown (5Y)Largest decline over 5 years | -97.77% | -88.23% | -9.54% |
Current DrawdownCurrent decline from peak | -91.22% | -15.09% | -76.13% |
Average DrawdownAverage peak-to-trough decline | -61.80% | -63.84% | +2.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.22% | 24.95% | -5.73% |
Volatility
STRO vs. OSCR - Volatility Comparison
Sutro Biopharma, Inc. (STRO) has a higher volatility of 18.26% compared to Oscar Health, Inc. (OSCR) at 15.53%. This indicates that STRO's price experiences larger fluctuations and is considered to be riskier than OSCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| STRO | OSCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.26% | 15.53% | +2.73% |
Volatility (6M)Calculated over the trailing 6-month period | 59.56% | 45.75% | +13.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 90.29% | 70.91% | +19.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 88.71% | 80.94% | +7.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.24% | 79.51% | +5.73% |
Dividends
STRO vs. OSCR - Dividend Comparison
Neither STRO nor OSCR has paid dividends to shareholders.
Financials
STRO vs. OSCR - Financials Comparison
This section allows you to compare key financial metrics between Sutro Biopharma, Inc. and Oscar Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
STRO and OSCR have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
STRO has higher volatility (18.26%) compared to OSCR (15.53%). In terms of maximum drawdown, STRO dropped -98.10% vs OSCR's -94.15%.
STRO currently has the higher Sharpe Ratio (2.24 vs 1.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for STRO and OSCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer